Intelligence Platform
Patents
Browse 3,494 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12233086
Biomarkers for neurogenerative disease
granted patentUS 12233090
Bispecific or-gate chimeric antigen receptor responsive to CD20 and CD19
granted patentUS 12233241
Methods and systems to validate physiologic waveform reliability and uses thereof
granted patentUS 12234260
Virus-like nanoparticles for oral delivery
granted patentUS 12234474
Method to prevent the myelin abnormalites associated with arginase deficiency
granted patentUS 12234263
Influenza vaccines
granted patentUS 12234461
Targeted non-viral DNA insertions
granted patentUS 12227482
Compounds and compositions for the treatment of cancer
granted patentUS 12227503
Compositions and methods for modulating hair growth
granted patentUS 12226386
Compositions and methods for treating biofilms
granted patentUS 12226489
Compounds and methods for treating gastrointestinal disease
granted patentUS 12227547
Modulators of CAS9 polypeptides and methods of use thereof
granted patentUS 12226546
Polyion complex polypeptide hydrogels and uses thereof
granted patentUS 12227562
Compositions and methods to treat viral infection and co-morbidities
granted patentUS 12226435
Bispecific OR-gate chimeric antigen receptor responsive to CD20 and CD19
granted patentUS 12222355
Therapeutic antibodies against ROR-1 protein and methods for use of same
granted patentUS 12221622
Modified pluripotent cells
granted patentUS 12221491
PSMD9 inhibitors for the treatment of hepatic lipid dysregulation
granted patentUS 12220389
Combination therapy for the treatment of tinnitus and other medical conditions
granted patentUS 12213977
Methods and compositions for treating melanoma
granted patentUS 12214014
Methods for scar reduction by converting scar fibroblasts into adipocytes with hair follic
granted patentUS 12215343
Methods and compositions for RNA-directed target DNA modification and for RNA-directed mod
granted patentUS 12209119
Method of treating rheumatoid arthritis using antibodies to oxidized phospholipids
granted patentUS 12209120
Activatable anti-VEGF scFv
granted